Variant report
Variant | esv3497374 |
---|---|
Chromosome Location | chr12:74677995-74679907 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:12)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:3)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:12 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CEBPB | chr12:74679616-74679818 | A549 | lung: | n/a | n/a |
2 | EP300 | chr12:74679573-74679634 | K562 | blood: | n/a | n/a |
3 | FOS | chr12:74679493-74679971 | MCF10A-Er-Src | breast: | n/a | n/a |
4 | FOS | chr12:74679624-74679824 | MCF10A-Er-Src | breast: | n/a | n/a |
5 | FOS | chr12:74679584-74679855 | MCF10A-Er-Src | breast: | n/a | n/a |
6 | FOS | chr12:74679572-74679913 | MCF10A-Er-Src | breast: | n/a | n/a |
7 | MYC | chr12:74679555-74679877 | MCF10A-Er-Src | breast: | n/a | n/a |
8 | POLR2A | chr12:74679445-74680609 | K562 | blood: | n/a | n/a |
9 | STAT3 | chr12:74679596-74679836 | MCF10A-Er-Src | breast: | n/a | n/a |
10 | STAT3 | chr12:74679458-74679900 | MCF10A-Er-Src | breast: | n/a | n/a |
11 | STAT3 | chr12:74679528-74679959 | MCF10A-Er-Src | breast: | n/a | n/a |
12 | TEAD4 | chr12:74679615-74680034 | ECC-1 | luminal epithelium: | n/a | n/a |
No data |
No data |
(count:3 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-KCNC2-2 | chr12:74679640-74679726 | ENSG00000251138 |
2 | lnc-KCNC2-2 | chr12:74679478-74679726 | ENSG00000251138 |
3 | lnc-KCNC2-2 | chr12:74678816-74678873 | ENSG00000251138 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000257183 | TF binding region |
RRAS | miRNA target sites |
DYNLL2 | miRNA target sites |
DNMT1 | miRNA target sites |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs373677381 | chr12:74678001-74678002 | Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs185608765 | chr12:74678022-74678023 | Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs148271802 | chr12:74678025-74678026 | Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs564616444 | chr12:74678068-74678069 | Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs530551390 | chr12:74678115-74678116 | Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs543458713 | chr12:74678133-74678134 | Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs544183325 | chr12:74678168-74678169 | Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs558047162 | chr12:74678170-74678171 | Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs529951005 | chr12:74678188-74678189 | Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs546595642 | chr12:74678196-74678197 | Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs528695939 | chr12:74678214-74678215 | Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs141171277 | chr12:74678234-74678235 | Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs532327404 | chr12:74678248-74678249 | Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs548348497 | chr12:74678342-74678343 | Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs188804055 | chr12:74678356-74678357 | Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs569364809 | chr12:74678393-74678394 | Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs66514235 | chr12:74678407-74678408 | Weak transcription Genic enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs548517764 | chr12:74678408-74678409 | Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs568372682 | chr12:74678415-74678416 | Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs534470188 | chr12:74678428-74678429 | Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs562421374 | chr12:74678439-74678440 | Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs386764286 | chr12:74678441-74678442 | Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs554065325 | chr12:74678442-74678443 | Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs577145048 | chr12:74678443-74678444 | Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs539629983 | chr12:74678445-74678446 | Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs556377644 | chr12:74678493-74678494 | Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs75548398 | chr12:74678508-74678509 | Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs150707639 | chr12:74678510-74678511 | Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs137983382 | chr12:74678596-74678597 | Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs112931987 | chr12:74678612-74678613 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs550324678 | chr12:74678615-74678616 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs574373499 | chr12:74678661-74678662 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs540260797 | chr12:74678666-74678667 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs73351780 | chr12:74678678-74678679 | Weak transcription Strong transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs532488770 | chr12:74678698-74678699 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs570391503 | chr12:74678734-74678735 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs142423752 | chr12:74678749-74678750 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs146368702 | chr12:74678758-74678759 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs531792142 | chr12:74678768-74678769 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs548410758 | chr12:74678833-74678834 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
41 | rs571410032 | chr12:74678847-74678848 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
42 | rs533916794 | chr12:74678936-74678937 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs139725371 | chr12:74678953-74678954 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs570801127 | chr12:74678985-74678986 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs144382966 | chr12:74679013-74679014 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs117229360 | chr12:74679020-74679021 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs576568647 | chr12:74679034-74679035 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs1554486 | chr12:74679054-74679055 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
49 | rs144416173 | chr12:74679173-74679174 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs574510168 | chr12:74679185-74679186 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Wilms tumour | 21544195 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Autism | 22495311 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 21949216 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 21637783 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 17899364 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Cancer | 16751803 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Melanoma | 18172304 | CNVD |
Glioblastoma multiforme | 21390271 | CNVD |
Cancer | 20164919 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 21785460 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Gastrointestinal stromal cancer | 20877625 | CNVD |
Burkitt''s lymphoma | 20823134 | CNVD |
abnormal development | 18461090 | CNVD |
Prostate cancer | 18632612 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
craniofacial dysmorphism | 21918468 | CNVD |
Breast cancer | 21364760 | CNVD |
Breast cancer | 17133270 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Breast cancer | 22032731 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
Breast cancer | 20409316 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr12:74636600-74678000 | Weak transcription | K562 | blood |
2 | chr12:74676000-74679000 | Weak transcription | HMEC | breast |
3 | chr12:74676200-74679200 | Weak transcription | Foreskin Keratinocyte Primary Cells skin03 | Skin |
4 | chr12:74678000-74678600 | Genic enhancers | K562 | blood |
5 | chr12:74678600-74678800 | Strong transcription | K562 | blood |
6 | chr12:74678800-74679400 | Weak transcription | K562 | blood |
7 | chr12:74679000-74679200 | Enhancers | HMEC | breast |
8 | chr12:74679000-74679400 | Enhancers | Placenta | Placenta |
9 | chr12:74679200-74679600 | Weak transcription | HMEC | breast |
10 | chr12:74679200-74680000 | Bivalent Enhancer | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
11 | chr12:74679200-74680000 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
12 | chr12:74679200-74681400 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
13 | chr12:74679400-74680400 | Enhancers | K562 | blood |
14 | chr12:74679600-74680200 | Enhancers | HMEC | breast |
15 | chr12:74679800-74680200 | Enhancers | NHEK | skin |